Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Design and Development of an Antigen Test for SARS-CoV-2 Nucleocapsid Protein to Validate the Viral Quality Assurance Panels.

Viruses - 24 Apr 2024

Ray Partha, Ledgerwood-Lee Melissa, Brickner Howard, Clark Alex E, Garretson Aaron, Graham Rishi, Van Zant Westley, Carlin Aaron F, Aronoff-Spencer Eliah S

Abstract excerpt

The continuing mutability of the SARS-CoV-2 virus can result in failures of diagnostic assays. To address this, we describe a generalizable bioinformatics-to-biology pipeline developed for the calibration and quality assurance of inactivated SARS-CoV-2 variant panels provided to Radical Acceleration of Diagnostics programs (RADx)-radical program awardees. A heuristic genetic analysis based on variant-defining...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Antibodies, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antigens, Viral

Share to Coronavirus Nucleocapsid Proteins

Share to COVID-19

Share to Enzyme-Linked Immunosorbent Assay

Share to Phosphoproteins

Share to SARS-CoV-2

Source

Open in PubMed Open full text

Identifiers

PMID: 38793544
DOI: 10.3390/v16050662
PMCID: PMC11125937

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Design and Development of an Antigen Test for SARS-CoV-2 Nucleocapsid Protein to Validate the Viral Quality Assurance Panels.PMID 38793544Read ↗

Bioinformatics-Based Design Strategy and Development of an Antigen Test for SARS-CoV-2 Nucleocapsid ProteinSemantic proximity Read ↗

Quantitative Mutation Analysis of Genes and Proteins of Major SARS-CoV-2 Variants of Concern and Interest.Semantic proximity Read ↗

Algorithm for the Quantitation of Variants of Concern for Rationally Designed Vaccines Based on the Isolation of SARS-CoV-2 Hawaiʻi Lineage B.1.243Semantic proximity Read ↗

Deep mutational scanning identifies SARS-CoV-2 Nucleocapsid escape mutations of currently available rapid antigen testsSemantic proximity Read ↗

Validation of RT-qPCR primers and probes for new and old variants of SARS-CoV-2 in a world scaleSemantic proximity Read ↗

SARS-CoV-2 Evolution and Its Implications for RT-PCR Diagnostic Performance.Semantic proximity Read ↗

Highly Specific Monoclonal Antibodies Against SARS-CoV-2 Nucleocapsid Antigen for Accurate Diagnosis of COVID-19Semantic proximity Read ↗

A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test PerformanceSemantic proximity Read ↗

Analytical comparison of nine SARS-CoV-2 antigen-detecting rapid diagnostic tests for emerging SARS-CoV-2 variantsSemantic proximity Read ↗

Deep mutational scanning identifies SARS-CoV-2 Nucleocapsid escape mutations of currently available rapid antigen tests.Semantic proximity Read ↗

Monitoring the SARS-CoV-2 pandemic: screening algorithm with single nucleotide polymorphism detection for the rapid identification of established and emerging variants.Semantic proximity Read ↗

Digital PCR Discriminates between SARS-CoV-2 Omicron Variants and Immune Escape Mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.